-
Fujifilm invests $188 million in a new cell culture media production facility
Time of Update: 2023-01-01
• Fujifilm's fifth media production site will be operated by Fujifilm Irving Technologies • Tripled the company's current liquid cell culture media production capacity • More than 100 new jobs, including bioprocessing engineer, manufacturing, production and logistics roles Fujifilm Corporation (Representative Director and CEO Goto Seiichi) announced a $188 million investment to build a cell culture media manufacturing facility in Research Triangle Park (RTP) in North Carolina, USA.
-
A glance of the recent development of 12 investment incubators of Viva Biotech
Time of Update: 2023-01-01
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
The latest results of the phase II study of QL1706 in the treatment of non-small cell lung cancer of Qilu Pharmaceutical were announced
Time of Update: 2023-01-01
By the end of the data, a total of 29 patients with EGFR wild-type advanced non-small cell lung cancer were enrolled and treated with QL1706 5 mg/kg combination chemotherapy (paclitaxel plus carboplatin or pemetrexed plus carboplatin) every 3 weeks (Q3W) and QL1706 5mg/kg Q3W maintenance therapy after 2 cycles until disease progression or other discontinuation events.
-
Up to $5 billion Akeso enters into a partnership and licensing agreement with Summit Therapeutics
Time of Update: 2023-01-01
62em; font-family:"Arial"; color:black; margin:0in; } On December 6, 2022, Akeso announced that it will grant Summit Therapeutics an exclusive license to develop and commercialize Evosi's (PD-1/VEGF bispecific antibody) in the United States, Canada, Europe and Japan.
-
Thermo Fisher Scientific Total Solutions for Air Pathogen Detection is available
Time of Update: 2023-01-01
At this stage, the global new crown pneumonia epidemic is still in the pandemic stage, and we must continue to adhere to the general strategy of "external defense against import, internal defense aga
-
More protection Adhere to high standards of pipe making technology
Time of Update: 2023-01-01
The above and you explain why the surface brightness ≠ surface roughness, this time to answer the customer's question - "why other people's pipes look brighter than Xinlai's". In-line bright solution
-
Sinovac Pharmaceutical joined hands with Tonghua Dongbao to accelerate the overseas expansion of domestic diabetes products
Time of Update: 2023-01-01
The cooperation between Sinovac and Tonghua Dongbao is an important step for the two companies to focus on high-quality biological drugs, give full play to their respective experience advantages, and achieve global commercialization of domestic diabetes products liraglutide.
-
"Qingke Biotech" received another 400 million yuan in Series B financing to accelerate the construction of "gene factory"
Time of Update: 2023-01-01
As a banner of the gene synthesis industry, Qingke Biotech has advanced underlying independent research and development capabilities (synthetic raw materials, synthetic instruments and equipment, synthesis technology), solid precipitation and leading layout all play an important role in the company's development.
-
Innovent and UNION Therapeutics announced the completion of the first patient dosing of a novel PDE4 inhibitor, Orismilast (IBI353), in a Phase I clinical trial in China
Time of Update: 2023-01-01
ROCKVILLE, USA, Suzhou, China, and HEILEUP, Denmark, Dec. 5, 2022The study (CTR 20222393) is a Phase I dose-escalation clinical study with multiple doses in healthy subjects, the main objective of which is to evaluate the pharmacokinetic (PK) characteristics, safety and tolerability of Chinese healthy subjects after receiving multiple doses of orismilast, in order to support the subsequent clinical development of orismilast in multiple indications such as psoriasis and atopic dermatitis (AD).
-
【Live Broadcast Trailer】Key points of operation of reverse osmosis equipment for pharmaceutical water systems
Time of Update: 2022-12-30
Introduction: At 14:00 pm on December 22, Jinderi will bring you a live broadcast on the theme of "Key Points of Reverse Osmosis Equipment Operation of Pharmaceutical Water System", sharing with you the content of reverse osmosis equipment process flow, operation and maintenance of reverse osmosis equipment, etc.
-
AI facilitates drug development for non-small cell lung cancer, and XtalPi has reached a strategic cooperation with EDDC in Singapore
Time of Update: 2022-12-30
62em; font-family:"Arial"; color:black; margin:0in; } XtalPi has partnered with Singapore's National Drug Development Platform to develop more effective and precise treatment options for lung cancer patients worldwide SHENZHEN & SINGAPORE, Dec. 20, 2022 /PRNewswire/ -- XtalPi and Singapore's National Drug Development Platform, the Center for Experimental Drug Discovery (EDDC), have reached a strategic collaboration to drive drug discovery with artificial intelligence (AI), automated experiments, and expert experience for non-small cell lung cancer (NSCLC) targets selected by EDDC.
-
BGI's monkeypox virus nucleic acid detection kit was CE-IVDD certified
Time of Update: 2022-12-30
The test kit is a clinical diagnostic aid for the detection of suspected MPV infection cases.
The test kit is a clinical diagnostic aid for the detection of suspected MPV infection cases.
The test kit is a clinical diagnostic aid for the detection of suspected MPV infection cases.
-
"Endovascular ultrasound diagnostic equipment" and "disposable endovascular ultrasound diagnostic catheter" were approved for marketing
Time of Update: 2022-12-30
The endovascular ultrasound diagnostic equipment adopts full digital signal transmission and single-array mechanical rotation design, and the digital transmission between the catheter controller and the imaging host is realized, which improves the integration and stability of the system while reducing the cost and making the image noise smaller.
-
Nine Days Bio's innovative AAV ophthalmic gene therapy drug was approved for clinical research
Time of Update: 2022-12-30
SKG0106 intraocular injection solution is an innovative ophthalmic gene therapy drug under development, consisting of a new adeno-associated virus (AAV) capsid independently developed by the company and an original transgene against neovascular growth, and its mechanism of action is to deliver SKG0106 into the eye through a single intravitreal injection, expressing anti-neovascular growth gene products after transduction of retinal cells, thereby inhibiting the progression of diseases related to fundus neovascularization.
-
To break the "old and difficult" of pharmaceutical wastewater, it is very important to improve reverse osmosis membrane technology
Time of Update: 2022-12-04
Compared with other traditional technologies, reverse osmosis technology has strong advantages, including simple process operation, high desalination efficiency, economical use in pharmaceutical water systems, efficient wastewater treatment, ensuring its treatment effect and efficiency, and reducing the overall wastewater reuse cost.
-
Major provincial projects accelerated: Jianshi Medical Wuxi base was opened
Time of Update: 2022-12-04
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Ensure the safety and efficiency of the production of automatic bag packaging machine, and the maintenance can not be ignored
Time of Update: 2022-12-04
js?cdnversion='+~(-new Date()/36e5)];Under the background of the rapid development of the pharmaceutical industry, the scale of the pharmaceutical equipment industry is expanding, and at the same time, the automatic innovation ability has also been improved.
-
【11.22 Live】Turnkey project and computerized verification
Time of Update: 2022-11-26
Among them, computerized system verification is one of the challenges faced by pharmaceutical companies in the process of digital transformation, and only through the verification of computerized systems can the quality of the system be guaranteed throughout its life cycle and always in a state of risk controllability.
-
Ana Cloud Live | full exposure of the three-day schedule, watch the winning gift!
Time of Update: 2022-11-26
com "Ana" cloud broadcastAs the world's leading event for analytical, laboratory technology, diagnostics and biochemical technology, analytica China 2022 will continue the online live broadcast service "Ana Cloud Live", which will start at 14:00 on November 14th!
-
10x Genomics launches new products to accelerate antibody discovery and TCR discovery
Time of Update: 2022-11-26
Antigen-specific BCR and TCR discovery processes Bryan Briney, assistant professor at the Scripps Institute, said: "BEAM technology will greatly improve our understanding of infectious disease biology and accelerate the discovery of rare monoclonal antibodies that have the specificity needed for treatment.
